Page last updated: 2024-10-23

bumetanide and Meniere Disease

bumetanide has been researched along with Meniere Disease in 2 studies

Meniere Disease: A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martínez Pelegrín, FT1
Argudo, F1
Sprekelsen, C1
Canteras, M1
Couloigner, V1
Loiseau, A1
Sterkers, O1
Amiel, C1
Ferrary, E1

Other Studies

2 other studies available for bumetanide and Meniere Disease

ArticleYear
[The bumetanide test and its audiometric use in endolymphatic hydrops].
    Anales otorrinolaringologicos ibero-americanos, 1982, Volume: 9, Issue:1

    Topics: Adult; Aged; Audiometry, Pure-Tone; Bone Conduction; Bumetanide; Diuretics; Female; Humans; Male; Me

1982
Effect of locally applied drugs on the endolymphatic sac potential.
    The Laryngoscope, 1998, Volume: 108, Issue:4 Pt 1

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetazolamide; Acid-Base Imbalance; Amiloride; Ani

1998